Startups
With offices in New Jersey, New York, and California. WBB Securities, LLC is a full-service, independent broker/dealer and registered investment adviser that is known for its insightful Investment Research & Banking covering biomedical, medical device, and life science firms. WBB's focus is to provide independent financial advisors with the tools and support necessary to serve their clients in a dynamic business environment. WBB has branches throughout the United States..
Founded in 2001, WBB remains privately-held to ensure that we continue to provide independent financial advisors with solutions-oriented, full-service operations, compliance, insurance support and the private-client experience in a low-cost platform. We serve ethical, entrepreneurial-minded financial advisors with the tools and expertise necessary to serve their clients and thrive in an increasingly challenging marketplace.
Our investment banking division specializes in financial advisory M&A services covering biotechnology, medical device, and life science firms. Our head banker, Steve Brozak, is regularly quoted and published in a variety of media, including ABC News, Bloomberg, and Forbes. Our research has garnered accolades from the Financial Times/Starmine ranking system (Pharmaceuticals in 2013). The Wall Street Journal's "Best of the Street" survey 2011 (Medical Equipment & Supplies), and the Financial Times/Starmine ranking system (Biotechnology in 2010).
Member FINRA/SIPC, a Registered Investment Adviser
Founded in 2001, WBB remains privately-held to ensure that we continue to provide independent financial advisors with solutions-oriented, full-service operations, compliance, insurance support and the private-client experience in a low-cost platform. We serve ethical, entrepreneurial-minded financial advisors with the tools and expertise necessary to serve their clients and thrive in an increasingly challenging marketplace.
Our investment banking division specializes in financial advisory M&A services covering biotechnology, medical device, and life science firms. Our head banker, Steve Brozak, is regularly quoted and published in a variety of media, including ABC News, Bloomberg, and Forbes. Our research has garnered accolades from the Financial Times/Starmine ranking system (Pharmaceuticals in 2013). The Wall Street Journal's "Best of the Street" survey 2011 (Medical Equipment & Supplies), and the Financial Times/Starmine ranking system (Biotechnology in 2010).
Member FINRA/SIPC, a Registered Investment Adviser
Overview
Location
United States, New Jersey, Cranford
Employees
11-50
Founded date
2001
Mentions in press and media 14
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Apr 8, 2019 | Value-based agreements could disrupt how we pay for new therapies | On Tuesday, the Senate Finance Committee will hold its second hearing in a series on drug pricing. Led by chairman Senator Chuck Grassley (R-Iowa) and ranking member Ron Wyden (D-Oregon), this hearing is a follow-up of the widely publicized... |
| Jul 20, 2017 | How Martin Shkreli used social media to fuel his short-selling shenanigans | Over the last several months, someone using the pseudonym “Art Doyle” released online reports — I use the word “reports” loosely — to attack several biotech stocks. Art Doyle, no doubt a truncation of Arthur Conan Doyle, the British author ... |
| Apr 3, 2012 | Navidea Biopharma: FDA pushes back PDUFA date of cancer drug | Navidea’s stock predictably took a hit after the news was announced and fell about 9 percent to around $3 a share in early trading Monday. Meanwhile, the company sought to downplay any concerns. “Neither this FDA decision nor the [new drug ... |
| Apr 2, 2012 | Athersys CEO: Stroke therapy could be one of biggest blockbusters ever | So were Van Bokkelen’s bold pronouncements a legitimate assessment of MultiStem’s outlook, or just empty puffery from a small biotech on a shoe-string budget badly in need of corporate partners? Steve Brozak, president of New Jersey-based r... |
| Mar 24, 2011 | Cancer diagnostics: With proxy fight looming, can Neoprobe deliver the goods? | As cancer diagnostics firm Neoprobe (NYSE Amex: NEOP) prepares for a potential proxy fight with Platinum-Montaur Life Sciences, the company’s largest investor, it’s worth taking a look at the Dublin, Ohio-based company’s exit potential. Out... |
| Mar 24, 2011 | Neoprobe looking ripe for acquisition; any takers? | Promoted Telemedicine’s potential to provide healthcare to the world’s most vulnerable Teladoc Health Head of R&D Yulun Wang highlights the impact of virtual care in underserved populations around the globe through the World Telehealth ... |
| Aug 10, 2010 | Power of Athersys stem cells may be underestimated, analyst says | A week ago, Athersys reported top-line results from a small Phase 1 trial to determine the safety and maximum dose of MultiStem for heart attack patients. MultiStem is an off-the-shelf stem cell treatment derived from the bone marrow of adu... |
| Dec 22, 2009 | New tax on medical device manufacturers could force Invacare to ship out jobs — MedCity Evening Read, Dec. 22, 2009 | Nationwide Children’s Hospital in Columbus recently was awarded an initial $5.5 million contract from the National Cancer Institute to serve as a biospecimen core resource for the Cancer Genome Atlas, a program co-managed by the cancer in... |
| Power of Athersys stem cells may be underestimated, analyst says | WBB Securities analyst Steve Brozak isn’t sure whether people understand how much better the stem cell therapy of Cleveland, Ohio-based Athersys Inc. is for treating heart attacks than the standard-of-care treatment. Brozak today raised his... |
Show more
Reviews 0
FAQ about WBB Securities LLC
When was WBB Securities LLC founded?
WBB Securities LLC was founded in 2001.
What has the press written about WBB Securities LLC?
Parsers VC has collected 14 articles mentioning WBB Securities LLC, among them “Value-based agreements could disrupt how we pay for new therapies” (Apr 8, 2019) and “How Martin Shkreli used social media to fuel his short-selling shenanigans” (Jul 20, 2017).
Is WBB Securities LLC still active?
Yes, WBB Securities LLC is active; its latest activity on Parsers VC dates from Apr 8, 2019.